(Q28217965)

Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review

21 January 2018

1 reference

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

21 January 2018

1 reference

Aspirin sensitivity: implications for patients with coronary artery disease

21 January 2018

1 reference

Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management

21 January 2018

1 reference

21 January 2018

Aspirin-sensitive asthma

1 reference

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

21 January 2018

1 reference

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

21 January 2018

1 reference

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study

21 January 2018

1 reference

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

21 January 2018

1 reference

Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan

21 January 2018

1 reference

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

21 January 2018

1 reference

21 January 2018

1 reference

Aspirin-induced asthma: clinical aspects, pathogenesis and management

21 January 2018

1 reference

Can NSAIDs intolerance disappear? A study of three cases

21 January 2018

1 reference

Best evidence topic report. Non-steroidal anti-inflammatory drugs and exacerbations of asthma in children.

21 January 2018

1 reference

Aspirin sensitivity and urticaria

21 January 2018

1 reference

Mechanism of chronic urticaria exacerbation by aspirin

21 January 2018

1 reference

The broken balance in aspirin hypersensitivity

21 January 2018

1 reference

Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria

21 January 2018

1 reference

Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma

21 January 2018

1 reference

Genetic mechanism of aspirin-induced urticaria/angioedema

21 January 2018

1 reference

Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic

21 January 2018

1 reference

Aspirin induced adverse skin reactions: new pathophysiological aspects

21 January 2018

1 reference

Testing for aspirin hypersensitivity

21 January 2018

1 reference

A new insight into aspirin-induced asthma

21 January 2018

1 reference

Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Report of the INTERASMA Working Group on Standardization of Inhalation Provocation Tests in Aspirin-induced Asthma. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma

21 January 2018

1 reference

Clinical features and diagnosis of aspirin induced asthma

21 January 2018

1 reference

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

21 January 2018

1 reference

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period

21 January 2018

1 reference

Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Individual monitoring of aspirin desensitization

21 January 2018

1 reference

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper

21 January 2018

1 reference

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug-induced reactions and desensitization

21 January 2018

1 reference

Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting

21 January 2018

1 reference

Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy

21 January 2018

1 reference

Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics

21 January 2018

1 reference

Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics

21 January 2018

1 reference

Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma

21 January 2018

1 reference

Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo

21 January 2018

1 reference

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

21 January 2018

1 reference

The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema

21 January 2018

1 reference

Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria

21 January 2018

1 reference

Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues

21 January 2018

1 reference

Tacrolimus reduces urinary excretion of leukotriene E(4) and inhibits aspirin-induced asthma to threshold dose of aspirin

21 January 2018

1 reference

Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes

21 January 2018

1 reference

Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib

21 January 2018

1 reference

Safety of COX-2 Inhibitors in Asthma Patients with Aspirin Hypersensitivity

21 January 2018

1 reference

Safety of a specific COX-2 inhibitor in aspirin-induced asthma

21 January 2018

1 reference

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

21 January 2018

1 reference

The safety of celecoxib in patients with aspirin-sensitive asthma

21 January 2018

1 reference

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

21 January 2018

1 reference

Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review.

21 January 2018

1 reference

Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance

21 January 2018

1 reference

Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease

21 January 2018

1 reference

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib

21 January 2018

1 reference

Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen

21 January 2018

1 reference

Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma

21 January 2018

1 reference

Adverse reactions to selective cyclooxygenase-2 inhibitors (coxibs)

21 January 2018

1 reference

Short-term tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema

21 January 2018

1 reference

Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib

21 January 2018

1 reference

Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties

21 January 2018

1 reference

Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects.

21 January 2018

1 reference

Salsalate cross-sensitivity in aspirin-sensitive patients with asthma.

21 January 2018

1 reference

Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance

21 January 2018

1 reference